The association between low lean mass and osteoporosis increases the risk of weakness, poor physical performance and frailty in Brazilian older adults: data from SARCOS study.
Journal
European journal of clinical nutrition
ISSN: 1476-5640
Titre abrégé: Eur J Clin Nutr
Pays: England
ID NLM: 8804070
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
22
01
2020
accepted:
05
09
2020
revised:
31
07
2020
pubmed:
20
9
2020
medline:
8
7
2021
entrez:
19
9
2020
Statut:
ppublish
Résumé
To characterize the phenotypes of older adults with low lean mass and osteoporosis, concomitantly or isolated, in regards to poor physical performance and frailty status. Cross-sectional analysis of the SARCopenia and OSteoporosis in Older Adults with Cardiovascular Diseases Study (SARCOS). Outpatient geriatric cardiology clinic. 385 older adults underwent DXA analysis. Low lean mass was diagnosed according to FNIH and low BMD by a T-score ≤ -2.5 SD. Subjects were grouped into: I-Low lean mass and Osteoporosis (LLMO); II-Low lean mass (LLM); III-Osteoporosis (OP), and IV-Controls. Poor physical performance was diagnosed by weakness or slow walking speed or impaired mobility. Frailty was diagnosed by CHS criteria. The mean age was 78.22 ± 7.16 years. The prevalence of LLMO, LLM, and OP were 14.8%, 39.5%, and 19.2%, respectively. LLMO subjects were older, predominantly women, with a high percentage of body fat (HTBF). LLM was represented by obese men, while individuals with OP were preferably women, older and leaner. In a regression analyses, LLMO presented an OR: 6.42 (2.63‒15.65; p < 0.001) for weakness, OR: 2.55 (1.09‒5.95; p = 0.030) for impaired mobility, and OR: 14.75 (2.72‒79.94; p = 0.002) for frailty. After adjusting for HTBF, the OR for frailty, decreased to 7.25 (1.11-47.21; p = 0.038). LLM and OP were associated only with weakness with an OR: 3.06 (1.36-6.84; p = 0.006) and OR: 3.14 (1.29-7.62; p = 0.011), respectively. In Brazilian older community-dwelling outpatient adults, the phenotype characterized by low lean mass and osteoporosis presents a higher association with impaired mobility, weakness and frailty status compared to the others phenotyeps and controls. A high percentage of body fat presents a synergistic effect with low lean mass and osteoporosis phenotype in regards to frailty.
Identifiants
pubmed: 32948866
doi: 10.1038/s41430-020-00753-w
pii: 10.1038/s41430-020-00753-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
446-455Références
Shephard RJ. Age and physical work capacity. Exp Aging Res. 1999;25:331–43. https://doi.org/10.1080/036107399243788.
doi: 10.1080/036107399243788.
pubmed: 10553515
Beaudart C, Rizzoli R, Bruyere O, Reginster JY, Biver E. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014;72:45 https://doi.org/10.1186/2049-3258-72-45.
doi: 10.1186/2049-3258-72-45.
pubmed: 25810912
pmcid: 4373245
Dempster DW. Osteoporosis and the burden of osteoporosis-related fractures. Am J Managed Care. 2011;17:S164–169.
Roux C, Wyman A, Hooven FH, Gehlbach SH, Adachi JD, Chapurlat RD, et al. Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int. 2012;23:2863–71. https://doi.org/10.1007/s00198-012-1935-8.
doi: 10.1007/s00198-012-1935-8.
pubmed: 22398855
pmcid: 4881739
Rikkonen T, Sirola J, Salovaara K, Tuppurainen M, Jurvelin JS, Honkanen R, et al. Muscle strength and body composition are clinical indicators of osteoporosis. Calcif Tissue Int. 2012;91:131–8. https://doi.org/10.1007/s00223-012-9618-1.
doi: 10.1007/s00223-012-9618-1.
pubmed: 22733383
Laurent MR, Dubois V, Claessens F, Verschueren SM, Vanderschueren D, Gielen E, et al. Muscle-bone interactions: from experimental models to the clinic? A critical update. Mol Cell Endocrinol. 2016;432:14–36. https://doi.org/10.1016/j.mce.2015.10.017.
doi: 10.1016/j.mce.2015.10.017.
pubmed: 26506009
Tagliaferri C, Wittrant Y, Davicco MJ, Walrand S, Coxam V. Muscle and bone, two interconnected tissues. Ageing Res Rev. 2015;21:55–70. https://doi.org/10.1016/j.arr.2015.03.002
doi: 10.1016/j.arr.2015.03.002
pubmed: 25804855
Brotto M, Johnson ML. Endocrine crosstalk between muscle and bone. Curr Osteoporos Rep. 2014;12:135–41. https://doi.org/10.1007/s11914-014-0209-0.
doi: 10.1007/s11914-014-0209-0.
pubmed: 24667990
pmcid: 4374433
Edwards MH, Gregson CL, Patel HP, Jameson KA, Harvey NC, Sayer AA, et al. Muscle size, strength, and physical performance and their associations with bone structure in the Hertfordshire Cohort Study. J Bone Min Res. 2013;28:2295–304. https://doi.org/10.1002/jbmr.1972
doi: 10.1002/jbmr.1972
Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–60. https://doi.org/10.1152/japplphysiol.00246.2003.
doi: 10.1152/japplphysiol.00246.2003.
pubmed: 14555665
Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76:473–81. https://doi.org/10.1093/ajcn/76.2.473.
doi: 10.1093/ajcn/76.2.473.
pubmed: 12145025
Binkley N, Buehring B. Beyond FRAX: it’s time to consider “sarco-osteopenia”. J Clin Densitom. 2009;12:413–6. https://doi.org/10.1016/j.jocd.2009.06.004
doi: 10.1016/j.jocd.2009.06.004
pubmed: 19733110
Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Muir SW, et al. Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc. 2015;16:290–5. https://doi.org/10.1016/j.jamda.2014.10.018.
doi: 10.1016/j.jamda.2014.10.018.
pubmed: 25512216
Crepaldi G, Maggi S. Sarcopenia and osteoporosis: a hazardous duet. J Endocrinol Invest. 2005;28:66–68.
doi: 10.1007/BF03345532
Frisoli A Jr., Chaves PH, Ingham SJ, Fried LP. Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Women’s Health and Aging Study (WHAS) II. Bone. 2011;48:952–7. https://doi.org/10.1016/j.bone.2010.12.025 .
doi: 10.1016/j.bone.2010.12.025
pubmed: 21195216
Wang YJ, Wang Y, Zhan JK, Tang ZY, He JY, Tan P, et al. Sarco-osteoporosis: prevalence and association with frailty in Chinese community-dwelling older adults. Int J Endocrinol. 2015;2015:482940 https://doi.org/10.1155/2015/482940.
doi: 10.1155/2015/482940.
pubmed: 26273298
pmcid: 4530239
Yoo JI, Kim H, Ha YC, Kwon HB, Koo KH. Osteosarcopenia in patients with hip fracture is related with high mortality. J Korean Med Sci. 2018;33:e27 https://doi.org/10.3346/jkms.2018.33.e27.
doi: 10.3346/jkms.2018.33.e27.
pubmed: 29318794
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. https://doi.org/10.1093/ageing/afy169 .
doi: 10.1093/ageing/afy169
pubmed: 30312372
Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547–58. https://doi.org/10.1093/gerona/glu010.
doi: 10.1093/gerona/glu010.
pubmed: 24737557
pmcid: 3991146
Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101. https://doi.org/10.1016/j.jamda.2013.11.025 .
doi: 10.1016/j.jamda.2013.11.025
pubmed: 24461239
WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series. WHO; 2000.894:i-xii–1-253.
World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. WHO Technical Report Series; 843. World Health Organization; 1994. p. 1–129.
Sjoblom S, Suuronen J, Rikkonen T, Honkanen R, Kroger H, Sirola J. Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas. 2013;75:175–80. https://doi.org/10.1016/j.maturitas.2013.03.016.
doi: 10.1016/j.maturitas.2013.03.016.
pubmed: 23628279
Gonzalez-Montalvo JI, Alarcon T, Gotor P, Queipo R, Velasco R, Hoyos R, et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatrics Gerontol Int. 2016;16:1021–7. https://doi.org/10.1111/ggi.12590.
doi: 10.1111/ggi.12590.
Yoshimura N, Muraki S, Oka H, Iidaka T, Kodama R, Kawaguchi H, et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys. Osteoporos Int. 2017;28:189–99. https://doi.org/10.1007/s00198-016-3823-0.
doi: 10.1007/s00198-016-3823-0.
pubmed: 27885410
Lamb SE, Keene DJ. Measuring physical capacity and performance in older people. Best Pract Res Clin Rheumatol. 2017;31:243–54. https://doi.org/10.1016/j.berh.2017.11.008 .
doi: 10.1016/j.berh.2017.11.008
pubmed: 29224699
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85–94.
doi: 10.1093/geronj/49.2.M85
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–156.
doi: 10.1093/gerona/56.3.M146
Stenholm S, Sallinen J, Koster A, Rantanen T, Sainio P, Heliovaara M, et al. Association between obesity history and hand grip strength in older adults–exploring the roles of inflammation and insulin resistance as mediating factors. J Gerontol A Biol Sci Med Sci. 2011;66:341–8. e-pub ahead of print 2011/02/12; glq226 [pii] https://doi.org/10.1093/gerona/glq226 .
Hulens M, Vansant G, Lysens R, Claessens AL, Muls E, Brumagne S. Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach. Int J Obes Relat Metab Disord. 2001;25:676–81. https://doi.org/10.1038/sj.ijo.0801560 .
doi: 10.1038/sj.ijo.0801560
pubmed: 11360150
Cooper R, Hardy R, Bann D, Aihie Sayer A, Ward KA, Adams JE, et al. Body mass index from age 15 years onwards and muscle mass, strength, and quality in early old age: findings from the MRC National Survey of Health and Development. J Gerontol A Biol Sci Med Sci. 2014;69:1253–9. https://doi.org/10.1093/gerona/glu039 .
doi: 10.1093/gerona/glu039
pubmed: 24682351
pmcid: 4158414
Marcus RL, Addison O, Kidde JP, Dibble LE, Lastayo PC. Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. J Nutr Health Aging. 2010;14:362–6. https://doi.org/10.1007/s12603-010-0081-2 .
doi: 10.1007/s12603-010-0081-2
pubmed: 20424803
pmcid: 3758242
Weinbrenner T, Schroder H, Escurriol V, Fito M, Elosua R, Vila J, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr. 2006;83:30–35. https://doi.org/10.1093/ajcn/83.1.30 .
doi: 10.1093/ajcn/83.1.30
pubmed: 16400046
Kanapuru B, Ershler WB. Inflammation, coagulation, and the pathway to frailty. Am J Med. 2009;122:605–13. https://doi.org/10.1016/j.amjmed.2009.01.030 .
doi: 10.1016/j.amjmed.2009.01.030
pubmed: 19559159
pmcid: 5999023
Howard C, Ferrucci L, Sun K, Fried LP, Walston J, Varadhan R, et al. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol. 2007;103:17–20. https://doi.org/10.1152/japplphysiol.00133.2007 .
doi: 10.1152/japplphysiol.00133.2007
pubmed: 17379753
pmcid: 2646087
Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15:914–20. https://doi.org/10.1038/nm.1964 .
doi: 10.1038/nm.1964
pubmed: 19633658
Mantovani G, Maccio A, Lai P, Massa E, Ghiani M, Santona MC. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms. Crit Rev Oncog. 1998;9:99–106. https://doi.org/10.1615/critrevoncog.v9.i2.10 .
doi: 10.1615/critrevoncog.v9.i2.10
pubmed: 9973244
Beyer I, Njemini R, Bautmans I, Demanet C, Bergmann P, Mets T. Inflammation-related muscle weakness and fatigue in geriatric patients. Exp Gerontol. 2012;47:52–59. https://doi.org/10.1016/j.exger.2011.10.005 .
doi: 10.1016/j.exger.2011.10.005
pubmed: 22032874
Stenholm S, Strandberg TE, Pitkala KH, Sainio P, Heliovaara M, Koskinen S. Midlife obesity and risk of frailty in old age during a 22-year follow-up in men and women: the Mini-Finland Follow-up Survey. J Gerontol A Biol Sci Med Sci. 2014;69:73–78. https://doi.org/10.1093/gerona/glt052.
doi: 10.1093/gerona/glt052.
pubmed: 23640762
Garcia-Esquinas E, Jose Garcia-Garcia F, Leon-Munoz LM, Carnicero JA, Guallar-Castillon P, Gonzalez-Colaco Harmand M, et al. Obesity, fat distribution, and risk of frailty in two population-based cohorts of older adults in Spain. Obes (Silver Spring). 2015;23:847–55. https://doi.org/10.1002/oby.21013 .
doi: 10.1002/oby.21013
Cawthon PM, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Establishing the link between lean mass and grip strength cut-points with mobility disability and other health outcomes: proceedings of the sarcopenia definition and outcomes consortium conference. J Gerontol A Biol Sci Med Sci. 2019. https://doi.org/10.1093/gerona/glz081 .
doi: 10.1093/gerona/glz081
pubmed: 30715162
pmcid: 7447857
Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Foger-Samwald U, Ellinger I. Immunology of osteoporosis: a mini-review. Gerontology. 2016;62:128–37. https://doi.org/10.1159/000431091 .
doi: 10.1159/000431091
pubmed: 26088283
Tieland M, Trouwborst I, Clark BC. Skeletal muscle performance and ageing. J cachexia, sarcopenia muscle. 2018;9:3–19. https://doi.org/10.1002/jcsm.12238 .
doi: 10.1002/jcsm.12238
Mo C, Romero-Suarez S, Bonewald L, Johnson M, Brotto M. Prostaglandin E2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation. Recent Pat Biotechnol. 2012;6:223–9.
doi: 10.2174/1872208311206030223
Gorski J, Huffman NT, Brotto L, Dallas M , Breggia A, Chittur SV, Huang J, Mo C, Liu Y, Seidah NG, Rosen C, Brotto M, Bonewald L. Potential role of leptin and BMP2 in osteocyte regulation of muscle mass and function in the adult skeleton and with age. in: ASBMR 2013 Annual Meeting; October 4-7, 2013; Baltimore Convention Center. Baltimore, MD: American Society for Bone and Mineral Research; 2013.
Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol. 2007;102:919–25. https://doi.org/10.1152/japplphysiol.00627.2006.
doi: 10.1152/japplphysiol.00627.2006.
pubmed: 17095641
Mohiti-Ardekani J, Soleymani-Salehabadi H, Owlia MB, Mohiti A. Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients. J bone Miner Metab. 2014;32:400–4. https://doi.org/10.1007/s00774-013-0511-4.
doi: 10.1007/s00774-013-0511-4.
pubmed: 24052207
Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia. 2011;54:1291–7. https://doi.org/10.1007/s00125-011-2155-z.
doi: 10.1007/s00125-011-2155-z.
pubmed: 21503740
Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R. Fi ATig. Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res. 2016;28:895–9. https://doi.org/10.1007/s40520-015-0494-1.
doi: 10.1007/s40520-015-0494-1.
pubmed: 26563287
Frisoli A Jr, Martin FC, Ingham SJ, Carvalho AC, Chaves P. The association of osteosarcopenia, sarcopenia and osteoporosis with weakness and mobility in older adults with cardiovascular disease: Data from Sarcos. Osteoporos Int. 2017;28:79 https://doi.org/10.1007/s00198-016-3530-x.
doi: 10.1007/s00198-016-3530-x.
Greeves JP, Cable NT, Reilly T, Kingsland C. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci. 1999;97:79–84.
doi: 10.1042/cs0970079
Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci. 1993;84:95–98.
doi: 10.1042/cs0840095